Company:  RESPONSE GENETICS INC (RGDX)
Form Type:  8-K
Filing Date:  8/14/2012 
CIK:  0001124608 
Address:  1640 Marengo St., 6th Floor 
City, State, Zip:  Los Angeles, California 90033 
Telephone:  323- 224-3900 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.27  
Change: 
0.01 (0.79%)  
Trade Time: 
03:59 PM EST  
Market Cap: 
$49.18M
Description of Business
Response Genetics, Inc. (the �Company�) was formed as a Delaware corporation in September 1999. We are a life sciences company engaged in the research and development of clinical diagnostic tests for cancer. Our mission is to provide personalized genetic information that will help guide physicians and patients in choosing the treatment from which a given patient is most likely to benefit. We currently generate revenues primarily from sales of our ResponseDX� diagnostic tests, which we launched in 2008, and by providing clinical trial testing services to pharmaceutical companies. Our proprietary technologies enable us to reliably and consistently extract ribonucleic acid (�RNA�) and deoxyribonucleic acid (�DNA�) from tumor specimens that are stored as formalin-fixed and paraffin-embedded (�FFPE�) specimens and thereby to analyze genetic information contained in these tissues.
Register for EDGAR Pro and access this filing in:     
  FORM 8-K
    SECTION 2 FINANCIAL INFORMATION
      Item 2.02 Results of Operations and Financial Condition.
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01. Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 99.1
    BALANCE SHEET
    INCOME STATEMENT
BROKERAGE PARTNERS